CSPC ZhongQi Pharmaceutical Technology Co., Ltd. clinical trials
A subsidiary of CSPC Pharmaceutical Group Limited
The registry lists 166 studies whose lead sponsor is CSPC ZhongQi Pharmaceutical Technology Co., Ltd.. 47 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Status
Registry sponsor names on this page
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.166 studies
Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 50 of 166. List all 166 → · All CSPC Pharmaceutical Group Limited studies →
- A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsRecruitingNCT07532655Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast CancerNot yet recruitingNCT07805135Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.Not yet recruitingNCT07798193Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia GravisRecruitingNCT06688435Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.RecruitingNCT07756996Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver FunctionRecruitingNCT07694843Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal FunctionRecruitingNCT07694869Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- SYH2095 for Advanced Malignant Tumors: Phase I StudyNot yet recruitingNCT07692776
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid HemangioendotheliomaNot yet recruitingNCT07684287Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With AcromegalyNot yet recruitingNCT07623824Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT07165886Phase 2/3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07418736Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085RecruitingNCT07412353Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver CancerNot yet recruitingNCT07282509Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid TumorsRecruitingNCT07241936Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)Not yet recruitingNCT07163364Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid TumorsRecruitingNCT06947291Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver MetastasesRecruitingNCT07117435Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- HB1801 Combined Treatment of HER2-positive Breast CancerNot yet recruitingNCT07116824Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast CancerNot yet recruitingNCT07083505Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerNot yet recruitingNCT06941142Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 InhibitorsNot yet recruitingNCT06929325Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionNot yet recruitingNCT06827431Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsNot yet recruitingNCT06771245Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of SYS6020 Injection in Refractory Active Systemic Lupus ErythematosusNot yet recruitingNCT06694298Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerRecruitingNCT06296706Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid TumorsRecruitingNCT06632574Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)RecruitingNCT06505395Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT06547333Phase 2/3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel(Albumin Bound)Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic CancerNot yet recruitingNCT06492941Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast CancerRecruitingNCT06313086Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)RecruitingNCT05875428Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of CM310 in Subjects With Moderate to Severe AsthmaRecruitingNCT05761028Phase 2/3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Not yet recruitingNCT06136988Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT05863325Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck CancerRecruitingNCT06011291Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- DP303c in Patients With HER2-positive Advanced Breast CancerNot yet recruitingNCT05901935Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic CancerRecruitingNCT05616494Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast CancerRecruitingNCT05720026Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)Not yet recruitingNCT05715840Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid TumorsNot yet recruitingNCT05508659Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT05407909Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid TumorsNot yet recruitingNCT05478785Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05445154Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-MutatedRecruitingNCT04716114Phase 3
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic MalignanciesNot yet recruitingNCT05055791Phase 1/2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With AcromegalyCompletedNCT07814651Phase 2
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy SubjectsCompletedNCT07508462Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Food-effect Study of Ammoxetine Hydrochloride Enteric-coated TabletsCompletedNCT07508501Phase 1
Sponsor listed in the registry: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.